The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

In 2012, a routine check-up revealed a lump in her neck that turned out to be thyroid cancer. The dancer, model, and mom of four encouraged people to seek routine preventive care. "I took that ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.

TSH (Thyroid-Stimulating Hormone) Test. Endocrine Society. Thyroid and Parathyroid Hormones. National Cancer Institute. Thyroxine. Romieu I, Dossus L, Barquera S, Blottière HM, Franks PW, Gunter M, ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

Shocking epiphany? The sun’s alignment with Mercury brings hidden information to light. And just in time! You were on the brink of making a defining financial or business move. Today’s ...

Oxidative Stress: Neuropathy, Excitability, and Neurodegeneration.